These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27426130)

  • 41. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
    Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
    Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic modulators as therapeutic targets in prostate cancer.
    Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
    Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The control of histone lysine methylation in epigenetic regulation.
    Völkel P; Angrand PO
    Biochimie; 2007 Jan; 89(1):1-20. PubMed ID: 16919862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental regulation of histone H3 methylation at lysine 4 in the porcine ovary.
    Seneda MM; Godmann M; Murphy BD; Kimmins S; Bordignon V
    Reproduction; 2008 Jun; 135(6):829-38. PubMed ID: 18502896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
    Wiencke JK; Zheng S; Morrison Z; Yeh RF
    Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation of histone 4's lysine 20: a critical analysis of the state of the field.
    Corvalan AZ; Coller HA
    Physiol Genomics; 2021 Jan; 53(1):22-32. PubMed ID: 33197229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic regulation of development by histone lysine methylation.
    Dambacher S; Hahn M; Schotta G
    Heredity (Edinb); 2010 Jul; 105(1):24-37. PubMed ID: 20442736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases.
    Lillico R; Sobral MG; Stesco N; Lakowski TM
    J Proteomics; 2016 Feb; 133():125-133. PubMed ID: 26721445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.
    Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM
    Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic targeting of chromatin: status and opportunities.
    Siklos M; Kubicek S
    FEBS J; 2022 Mar; 289(5):1276-1301. PubMed ID: 33982887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.
    Duan YC; Zhang SJ; Shi XJ; Jin LF; Yu T; Song Y; Guan YY
    Eur J Med Chem; 2021 Oct; 222():113588. PubMed ID: 34107385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic regulation of histone H3 methylation at lysine 4 in mammalian spermatogenesis.
    Godmann M; Auger V; Ferraroni-Aguiar V; Di Sauro A; Sette C; Behr R; Kimmins S
    Biol Reprod; 2007 Nov; 77(5):754-64. PubMed ID: 17634443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decoding the histone H4 lysine 20 methylation mark.
    Balakrishnan L; Milavetz B
    Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):440-52. PubMed ID: 20735237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone lysine methylation: an epigenetic modification?
    Blackledge NP; Klose RJ
    Epigenomics; 2010 Feb; 2(1):151-61. PubMed ID: 22122751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states.
    Wu R; Terry AV; Singh PB; Gilbert DM
    Mol Biol Cell; 2005 Jun; 16(6):2872-81. PubMed ID: 15788566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BUR kinase selectively regulates H3 K4 trimethylation and H2B ubiquitylation through recruitment of the PAF elongation complex.
    Laribee RN; Krogan NJ; Xiao T; Shibata Y; Hughes TR; Greenblatt JF; Strahl BD
    Curr Biol; 2005 Aug; 15(16):1487-93. PubMed ID: 16040246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.